894769-77-8

Basic information

• Product Name: 1-BOC-4-CYANO-4-(4-FLUOROBENZYL)-PIPERIDINE
• Synonyms: 1-BOC-4-CYANO-4-(4-FLUOROBENZYL)-PIPERIDINE;tert-Butyl 4-cyano-4-(4-fluorobenzyl)piperidine-1-carboxylate
• CAS NO: 894769-77-8
• Molecular Formula: C₁₈H₂₃FN₂O₂
• Molecular Weight: 318.39
• Mol File: 894769-77-8.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 1-BOC-4-CYANO-4-(4-FLUOROBENZYL)-PIPERIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-BOC-4-CYANO-4-(4-FLUOROBENZYL)-PIPERIDINE(894769-77-8)
• EPA Substance Registry System: 1-BOC-4-CYANO-4-(4-FLUOROBENZYL)-PIPERIDINE(894769-77-8)

Safety Data

• Hazardous Substances Data: 894769-77-8(Hazardous Substances Data)

Usage

General Description

1-BOC-4-CYANO-4-(4-FLUOROBENZYL)-PIPERIDINE is a chemical compound that belongs to the class of piperidines. It is characterized by the presence of a cyano group and a 4-fluorobenzyl substituent on the piperidine ring. The compound is often used as a building block in organic synthesis and medicinal chemistry, where it can serve as a precursor for the synthesis of various pharmaceuticals and biologically active molecules. It is also commonly employed in research and academic laboratories as a reagent and intermediate in the development of new chemical entities. Its unique structural features and chemical reactivity make it a valuable tool in the production of diverse compounds with potential applications in drug discovery and development.

Upstream product

• 91419-52-2 1-tert-butoxycarbonyl-4-cyanopiperidine 
• 459-46-1 4-Fluorobenzyl bromide 

Downstream Products

• 894854-54-7 4-(4-fluorobenzyl)piperidine-4-carbonitrile 
• 894770-15-1 4-(4-fluorobenzyl)piperidine-4-carbonitrile hydrochloride 
• 894769-82-5 tert-butyl 4-(4-fluorobenzyl)-4-formylpiperidine-1-carboxylate 
• 894769-76-7 4-(aminomethyl)-4-[(4-fluorophenyl)methyl]-1-piperidinecarboxylic acid 1,1-dimethylethyl ester 

Relevant articles and documents

COMPOUNDS, COMPOSITIONS, AND METHODS OF USE

Described herein are compounds that act as CYP46A1 inhibitors, compositions comprising these compounds, and methods of their use into treating neurodegenerative diseases and the like, or a pharmaceutically active salt thereof. The present invention relates to compounds represented by the formula wherein each symbol is as defined in the specification, or a pharmaceutically active salt thereof.

NOVEL BENZODIOXANE AND BENZOXAZINE DERIVATIVES USEFUL AS CC CHEMOKINE RECEPTOR LIGANDS

The present invention relates to benzodioxane and benzoxazine derivatives that act as ligands for CC chemokine receptors, such as CCR1. The invention also relates to methods of preparing the compounds, compositions containing the compounds, and to methods of treatment using the compounds.

PIPERIDINE DERIVATIVES AS ANTAGONISTS OF THE CC CHEMOKINE RECEPTOR CCR1 AND THEIR USE AS ANTI-INFLAMMATORY AGENTS

Piperidine derivatives of the following formulae (I) and (II) and their pharmaceutically acceptable salts, which are functional antagonists of the CC chemokine receptor CCR1 and are thus useful as anti inflammatory agents, a pharmaceutical compositions co